• Title/Summary/Keyword: 갑상선 수술

Search Result 194, Processing Time 0.024 seconds

성대마비의 수술적 치료

  • 손영익
    • Proceedings of the KSLP Conference
    • /
    • 2003.11a
    • /
    • pp.167-169
    • /
    • 2003
  • 성대의 마비는 그 원인과 정도에 따라 애성, 연하장애, 호흡장애 등 다양한 기능 결손을 초래하게 되므로, 마비된 성대에 의한 불편을 외과적으로 처치하기 이전에 반드시 마비의 원인에 대한 이해와, 환자의 불편에 대한 정확한 이해가 선행되어야만 적합한 술식을 선택할 수 있다. 예를 들어 두개저수술의 합병증으로 갑자기 발생된 성대마비와 갑상선암에 의하여 서서히 진행된 성대마비의 경우 그 예후나 경과가 전혀 다른 질환이라 할 수 있기 때문이다. (중략)

  • PDF

Serial Changes of Serum Thyroid-Stimulating Hormone after Total Thyroidectomy or Withdrawal of Suppressive Thyroxine Therapy in Patients with Differentiated Thyroid Cancer (분화성 갑상선 암 환자에서 갑상선 전절제술후 또는 갑상선 호르몬 억제 요법 중단에 따른 갑상선 자극호르몬의 변화)

  • Bae, Jin-Ho;Lee, Jae-Tae;Seo, Ji-Hyoung;Jeong, Shin-Young;Jung, Jin-Hyang;Park, Ho-Yong;Kim, Jung-Guk;Ahn, Byeong-Cheol;Sohn, Jin-Ho;Kim, Bo-Wan;Park, June-Sik;Lee, Kyu-Bo
    • The Korean Journal of Nuclear Medicine
    • /
    • v.38 no.6
    • /
    • pp.516-521
    • /
    • 2004
  • Background: Radioactive iodine (RAI) therapy and whole-body scanning are the fundamentals of treatment and follow-up of patients with differentiated thyroid cancer. It is generally accepted that a Thyroid-Stimulating Hormone (TSH) level of at least 30 ${\mu}U/ml$ is a prerequisite for the effective use of RAI, and that it requires 4-6 weeks of off-thyroxine to attain these levels. Because thyroxine withdrawal and the consequent hypothyroidism are often poorly tolerated, and occasionally might be hazardous, it is important to be certain that these assumptions are correct. We have measured serial changes in serum TSH after total thyroidectomy or withdrawl of thyroxine in patients with thyroid cancer. Subjects and Methods: Serum TSH levels were measured weekly after thyroidectomy in 10 patients (group A) and after the discontinuation of thyroxine in 12 patients (group B). Symptoms and signs of hypothyroidism were also evaluated weekly by modified Billewicz diagnostic index. Results: By the second week, 78% of group A patients and 17% of group B patients had serum TSH levels ${\geq}30{\mu}U/ml$. By the third week, 89% of group A patients and 90% of group B patients had serum TSH levels ${\geq}30{\mu}U/ml$. By the fourth week, all patients in two groups achieved target TSH levels and there were no overt hypothyroidism. Conclusion: in all patients, serum TSH elevated to the target concentration (${\geq}30{\mu}U/ml$) within 4 weeks without significant manifestation of hypothyroidism. The schedule of RAI administration could be adjusted to fit the needs and circumstances of individual patients with a shorter preparation period than the conventional.

Metastasis of Poorly Differentiated Thyroid Carcinoma to the Sternum: A Case Report (복장뼈로 전이된 저분화 갑상선암: 증례 보고)

  • Hae-Jung Kim; Inyoung Youn
    • Journal of the Korean Society of Radiology
    • /
    • v.81 no.4
    • /
    • pp.939-944
    • /
    • 2020
  • Sternal metastasis of poorly differentiated thyroid carcinoma (PDTC) is rare, and only a few cases have been reported in the literature. Here, we report a case of sternal metastasis of PDTC in an 83-year-old woman, 2 years after right hemithyroidectomy, treated with sternal resection and reconstruction.